Managing Pediatric Emergencies
Adapts emergency protocols for pediatric patients using weight-based dosing, age-adjusted vital sign norms, and the Broselow tape methodology for equipment sizing and medication dosing.
Why This Skill Exists
Children are not small adults — their physiology, anatomy, pharmacokinetics, and disease presentations differ fundamentally from adults. Medication errors in pediatric emergency care occur at 3 times the rate of adult care, with dosing errors being the most common type. A 10-fold dosing error — the most dangerous medication error in pediatrics — occurs in approximately 1 in 1,000 pediatric ED visits and can be lethal with medications like epinephrine, insulin, and opioids.
The Broselow-Luten system provides length-based weight estimation and pre-calculated equipment sizes and drug doses. PALS (Pediatric Advanced Life Support) protocols from the AHA define resuscitation algorithms, and the Emergency Medical Services for Children (EMSC) program sets national standards for pediatric emergency readiness. Only 18% of US emergency departments meet all pediatric readiness standards, making systematic protocol adherence essential for safe pediatric emergency care.
Checkpoint A: Pre-Draft Intake (Mandatory)
- What is the child's age and weight? (Default: if weight unknown, use Broselow tape or age-based estimation: weight in kg = (age × 2) + 8 for ages 1-10)
- What are the presenting symptoms and duration? (Default: document with caregiver as historian)
- What are the vital signs? (Default: compare against age-adjusted normal ranges)
- What is the child's immunization status? (Default: query and document)
- What is the child's medication and allergy history? (Default: query caregiver and document)
- Who is the legal guardian present and is consent available? (Default: document legal guardian identity)
- Are there any chronic medical conditions or special healthcare needs? (Default: query for technology dependence — tracheostomy, VP shunt, G-tube, home ventilator)
- What is the child's birth history if <1 year? (Default: gestational age, birth weight, NICU course)
Documents to Request
- Growth chart and prior weight measurements
- Immunization records
- Medication list and known allergies
- Prior ED visit records
- Subspecialist notes for children with complex medical conditions
- School health plan or emergency care plan if applicable
Step 1: Age-Adjusted Vital Sign Assessment
Normal Pediatric Vital Sign Ranges
| Age |
Heart Rate |
Respiratory Rate |
SBP (mmHg) |
Weight (kg) |
| Newborn |
120-160 |
30-60 |
60-80 |
3-4 |
| 1-12 months |
100-160 |
25-40 |
70-100 |
4-10 |
| 1-3 years |
90-150 |
20-30 |
80-110 |
10-15 |
| 4-5 years |
80-140 |
20-25 |
85-110 |
16-20 |
| 6-12 years |
70-120 |
15-20 |
90-120 |
20-40 |
| 13-18 years |
60-100 |
12-20 |
100-130 |
40-70 |
Minimum acceptable SBP by age: SBP = 70 + (age in years × 2) for ages 1-10. SBP <90 for age >10.
Pediatric Assessment Triangle (PAT)
Rapid across-the-room assessment before touching the child:
- Appearance: Tone, interactiveness, consolability, look/gaze, speech/cry (TICLS mnemonic)
- Work of Breathing: Nasal flaring, retractions, tripoding, head bobbing, audible sounds
- Circulation to Skin: Pallor, mottling, cyanosis
| PAT Result |
Interpretation |
Urgency |
| All normal |
Stable |
Continue systematic evaluation |
| Abnormal appearance only |
CNS dysfunction or systemic illness |
High priority |
| Abnormal breathing only |
Respiratory distress |
Immediate respiratory support |
| Abnormal appearance + breathing |
Respiratory failure |
Immediate intervention |
| Abnormal appearance + circulation |
Compensated shock → decompensating |
Immediate fluid resuscitation |
| All abnormal |
Cardiopulmonary failure |
Resuscitation team activation |
Step 2: Weight-Based Medication Dosing
Critical Emergency Medications (weight-based)
| Medication |
Dose |
Route |
Max Single Dose |
Notes |
| Epinephrine (cardiac arrest) |
0.01 mg/kg (0.1 mL/kg of 1:10,000) |
IV/IO |
1 mg |
NEVER use 1:1,000 concentration IV |
| Epinephrine (anaphylaxis) |
0.01 mg/kg (0.01 mL/kg of 1:1,000) |
IM |
0.3 mg (<30 kg), 0.5 mg (≥30 kg) |
Anterolateral thigh |
| Atropine |
0.02 mg/kg |
IV/IO |
0.5 mg |
Minimum dose 0.1 mg (below this may cause paradoxical bradycardia) |
| Amiodarone |
5 mg/kg |
IV/IO |
300 mg |
For VF/pulseless VT |
| Adenosine |
0.1 mg/kg (1st), 0.2 mg/kg (2nd) |
Rapid IV push |
6 mg (1st), 12 mg (2nd) |
Must be rapid push with flush |
| Dextrose |
D10W: 5 mL/kg; D25W: 2 mL/kg |
IV |
— |
D50 is NOT used in children <8 years |
| Diazepam (status epilepticus) |
0.2 mg/kg |
IV; 0.5 mg/kg rectal |
10 mg IV; 20 mg rectal |
Second-line after midazolam |
| Midazolam (status epilepticus) |
0.1 mg/kg IV; 0.2 mg/kg IM/IN |
IV/IM/IN |
10 mg |
First-line for active seizures |
| Ceftriaxone (meningitis) |
50 mg/kg |
IV |
2 g |
Do not delay for LP |
Fluid Resuscitation
- Initial bolus: 20 mL/kg isotonic crystalloid (NS or LR) over 5-20 minutes
- Reassess after each bolus: heart rate, capillary refill, mental status, blood pressure
- Repeat up to 60 mL/kg in the first hour for septic shock
- If no improvement after 40-60 mL/kg: initiate vasopressor support (epinephrine or norepinephrine)
Step 3: Pediatric Resuscitation (PALS Framework)
Cardiac Arrest Algorithm
Shockable rhythms (VF / pulseless VT):
- CPR 2 min → rhythm check
- Defibrillation: 2 J/kg (1st), 4 J/kg (2nd and subsequent)
- Epinephrine 0.01 mg/kg IV/IO every 3-5 min
- Amiodarone 5 mg/kg IV/IO (after 3rd shock)
- Continue CPR cycles; address reversible causes (Hs and Ts)
Non-shockable rhythms (asystole / PEA):
- CPR 2 min → rhythm check
- Epinephrine 0.01 mg/kg IV/IO every 3-5 min
- Address reversible causes (Hs and Ts)
Hs and Ts (Reversible Causes)
- Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo/hyperkalemia, Hypothermia, Hypoglycemia
- Tension pneumothorax, Tamponade, Toxins, Thrombosis (PE/coronary)
Equipment Sizing by Broselow Color Zone
| Color |
Weight (kg) |
ETT (uncuffed) |
ETT (cuffed) |
Laryngoscope |
NG Tube |
| Grey |
3-5 |
3.5 |
3.0 |
Miller 1 |
8 Fr |
| Pink |
6-7 |
3.5-4.0 |
3.0-3.5 |
Miller 1 |
8 Fr |
| Red |
8-9 |
4.0 |
3.5 |
Miller 1-2 |
10 Fr |
| Purple |
10-11 |
4.5 |
4.0 |
Miller 2 |
10 Fr |
| Yellow |
12-14 |
5.0 |
4.5 |
Mac 2 |
12 Fr |
| White |
15-18 |
5.5 |
5.0 |
Mac 2 |
12 Fr |
| Blue |
19-23 |
6.0 |
5.5 |
Mac 2 |
14 Fr |
| Orange |
24-29 |
6.5 |
6.0 |
Mac 3 |
14 Fr |
| Green |
30-36 |
7.0 |
6.5 |
Mac 3 |
16 Fr |
Step 4: Common Pediatric Emergency Presentations
Fever Without Source (Age-Based Approach)
| Age |
Approach |
Key Concern |
| 0-28 days |
Full sepsis workup: CBC, blood culture, UA + culture, LP, CXR; admit + empiric antibiotics (ampicillin + gentamicin or cefotaxime) |
Late-onset GBS, E. coli, HSV; HSV PCR if risk factors |
| 29-60 days |
Risk stratify using Rochester/Philadelphia/Step-by-Step criteria; low-risk may be managed outpatient with close follow-up |
Serious bacterial infection rate 7-10% |
| 61-90 days |
UA + culture; blood culture if ill-appearing; LP if <2 months or ill-appearing |
UTI is the most common source |
| 3-36 months |
Evaluate for UTI (especially uncircumcised males <6 months, females <2 years); CXR if respiratory symptoms |
Pneumonia, UTI, occult bacteremia (now rare post-PCV13) |
Pediatric Status Epilepticus Protocol
- 0-5 min: Stabilize (ABCs, glucose, oxygen); benzodiazepine first-line
- 5 min: Midazolam 0.2 mg/kg IM/IN or lorazepam 0.1 mg/kg IV (max 4 mg)
- 10 min: Repeat benzodiazepine once if still seizing
- 15-20 min: Second-line: fosphenytoin 20 mg PE/kg IV or levetiracetam 40-60 mg/kg IV or valproate 20-40 mg/kg IV
- >30 min: Refractory status epilepticus — consider continuous infusion (midazolam, pentobarbital) and ICU admission
Checkpoint B: Post-Draft Alignment (Mandatory)
- Was the child's weight accurately determined (measured, Broselow, or age-based estimate) and documented?
- Were all medication doses calculated per kilogram with maximum doses verified?
- Were vital signs compared against age-adjusted normal ranges?
- Were age-specific protocols applied (neonatal fever workup, Broselow equipment sizing)?
- Was the legal guardian identified and informed consent documented?
Quality Audit
Guidelines
- Always weigh children in kilograms — never estimate when a scale is available. Kilogram-only scales prevent the lb/kg conversion errors that account for the majority of 10-fold dosing mistakes.
- Use the Broselow tape for all children where actual weight is unknown — tape-based weight estimation is accurate within 10-20% for the majority of children and is far safer than ad hoc guessing.
- Never administer D50W (50% dextrose) to children under 8 years — use D10W (5 mL/kg) for neonates and infants, D25W (2 mL/kg) for children 1-8 years.
- All febrile neonates (≤28 days) require full sepsis workup including lumbar puncture and empiric antibiotics — do not discharge pending cultures regardless of appearance.
- Verify the concentration of epinephrine before every administration — 1:10,000 (0.1 mg/mL) for IV cardiac arrest, 1:1,000 (1 mg/mL) for IM anaphylaxis. Concentration confusion is one of the most lethal medication errors in pediatrics.
- Apply the Pediatric Assessment Triangle before touching the child — this 30-second across-the-room assessment provides more prognostic information than vital signs alone.
- Screen for child abuse in all pediatric injury presentations — bruising in non-mobile infants (pre-cruising age), patterned injuries, and history inconsistent with developmental stage require mandatory reporting.
- Involve parents/caregivers in resuscitation decisions and allow family presence during resuscitation when supported by institutional policy — family presence is endorsed by AHA and AAP.
1---2name: managing-pediatric-emergencies3description: Adapts emergency protocols for pediatric patients using weight-based dosing and Broselow methodology. Use when treating pediatric emergencies, calculating pediatric doses, or managing pediatric resuscitations.4---5
6# Managing Pediatric Emergencies
7
8Adapts emergency protocols for pediatric patients using weight-based dosing, age-adjusted vital sign norms, and the Broselow tape methodology for equipment sizing and medication dosing.
9
10## Why This Skill Exists
11
12Children are not small adults — their physiology, anatomy, pharmacokinetics, and disease presentations differ fundamentally from adults. Medication errors in pediatric emergency care occur at 3 times the rate of adult care, with dosing errors being the most common type. A 10-fold dosing error — the most dangerous medication error in pediatrics — occurs in approximately 1 in 1,000 pediatric ED visits and can be lethal with medications like epinephrine, insulin, and opioids.
13
14The Broselow-Luten system provides length-based weight estimation and pre-calculated equipment sizes and drug doses. PALS (Pediatric Advanced Life Support) protocols from the AHA define resuscitation algorithms, and the Emergency Medical Services for Children (EMSC) program sets national standards for pediatric emergency readiness. Only 18% of US emergency departments meet all pediatric readiness standards, making systematic protocol adherence essential for safe pediatric emergency care.
15
16---
17
18## Checkpoint A: Pre-Draft Intake (Mandatory)
19
201. What is the child's age and weight? (Default: if weight unknown, use Broselow tape or age-based estimation: weight in kg = (age × 2) + 8 for ages 1-10)
212. What are the presenting symptoms and duration? (Default: document with caregiver as historian)
223. What are the vital signs? (Default: compare against age-adjusted normal ranges)
234. What is the child's immunization status? (Default: query and document)
245. What is the child's medication and allergy history? (Default: query caregiver and document)
256. Who is the legal guardian present and is consent available? (Default: document legal guardian identity)
267. Are there any chronic medical conditions or special healthcare needs? (Default: query for technology dependence — tracheostomy, VP shunt, G-tube, home ventilator)
278. What is the child's birth history if <1 year? (Default: gestational age, birth weight, NICU course)
28
29### Documents to Request
30
31- Growth chart and prior weight measurements
32- Immunization records
33- Medication list and known allergies
34- Prior ED visit records
35- Subspecialist notes for children with complex medical conditions
36- School health plan or emergency care plan if applicable
37
38---
39
40## Step 1: Age-Adjusted Vital Sign Assessment
41
42### Normal Pediatric Vital Sign Ranges
43
44| Age | Heart Rate | Respiratory Rate | SBP (mmHg) | Weight (kg) |
45|-----|-----------|-----------------|-------------|-------------|
46| Newborn | 120-160 | 30-60 | 60-80 | 3-4 |
47| 1-12 months | 100-160 | 25-40 | 70-100 | 4-10 |
48| 1-3 years | 90-150 | 20-30 | 80-110 | 10-15 |
49| 4-5 years | 80-140 | 20-25 | 85-110 | 16-20 |
50| 6-12 years | 70-120 | 15-20 | 90-120 | 20-40 |
51| 13-18 years | 60-100 | 12-20 | 100-130 | 40-70 |
52
53**Minimum acceptable SBP by age:** SBP = 70 + (age in years × 2) for ages 1-10. SBP <90 for age >10.
54
55### Pediatric Assessment Triangle (PAT)
56Rapid across-the-room assessment before touching the child:
57- **Appearance:** Tone, interactiveness, consolability, look/gaze, speech/cry (TICLS mnemonic)
58- **Work of Breathing:** Nasal flaring, retractions, tripoding, head bobbing, audible sounds
59- **Circulation to Skin:** Pallor, mottling, cyanosis
60
61| PAT Result | Interpretation | Urgency |
62|------------|---------------|---------|
63| All normal | Stable | Continue systematic evaluation |
64| Abnormal appearance only | CNS dysfunction or systemic illness | High priority |
65| Abnormal breathing only | Respiratory distress | Immediate respiratory support |
66| Abnormal appearance + breathing | Respiratory failure | Immediate intervention |
67| Abnormal appearance + circulation | Compensated shock → decompensating | Immediate fluid resuscitation |
68| All abnormal | Cardiopulmonary failure | Resuscitation team activation |
69
70---
71
72## Step 2: Weight-Based Medication Dosing
73
74### Critical Emergency Medications (weight-based)
75
76| Medication | Dose | Route | Max Single Dose | Notes |
77|------------|------|-------|-----------------|-------|
78| Epinephrine (cardiac arrest) | 0.01 mg/kg (0.1 mL/kg of 1:10,000) | IV/IO | 1 mg | NEVER use 1:1,000 concentration IV |
79| Epinephrine (anaphylaxis) | 0.01 mg/kg (0.01 mL/kg of 1:1,000) | IM | 0.3 mg (<30 kg), 0.5 mg (≥30 kg) | Anterolateral thigh |
80| Atropine | 0.02 mg/kg | IV/IO | 0.5 mg | Minimum dose 0.1 mg (below this may cause paradoxical bradycardia) |
81| Amiodarone | 5 mg/kg | IV/IO | 300 mg | For VF/pulseless VT |
82| Adenosine | 0.1 mg/kg (1st), 0.2 mg/kg (2nd) | Rapid IV push | 6 mg (1st), 12 mg (2nd) | Must be rapid push with flush |
83| Dextrose | D10W: 5 mL/kg; D25W: 2 mL/kg | IV | — | D50 is NOT used in children <8 years |
84| Diazepam (status epilepticus) | 0.2 mg/kg | IV; 0.5 mg/kg rectal | 10 mg IV; 20 mg rectal | Second-line after midazolam |
85| Midazolam (status epilepticus) | 0.1 mg/kg IV; 0.2 mg/kg IM/IN | IV/IM/IN | 10 mg | First-line for active seizures |
86| Ceftriaxone (meningitis) | 50 mg/kg | IV | 2 g | Do not delay for LP |
87
88### Fluid Resuscitation
89- **Initial bolus:** 20 mL/kg isotonic crystalloid (NS or LR) over 5-20 minutes
90- **Reassess** after each bolus: heart rate, capillary refill, mental status, blood pressure
91- **Repeat** up to 60 mL/kg in the first hour for septic shock
92- **If no improvement after 40-60 mL/kg:** initiate vasopressor support (epinephrine or norepinephrine)
93
94---
95
96## Step 3: Pediatric Resuscitation (PALS Framework)
97
98### Cardiac Arrest Algorithm
99
100**Shockable rhythms (VF / pulseless VT):**
1011. CPR 2 min → rhythm check
1022. Defibrillation: 2 J/kg (1st), 4 J/kg (2nd and subsequent)
1033. Epinephrine 0.01 mg/kg IV/IO every 3-5 min
1044. Amiodarone 5 mg/kg IV/IO (after 3rd shock)
1055. Continue CPR cycles; address reversible causes (Hs and Ts)
106
107**Non-shockable rhythms (asystole / PEA):**
1081. CPR 2 min → rhythm check
1092. Epinephrine 0.01 mg/kg IV/IO every 3-5 min
1103. Address reversible causes (Hs and Ts)
111
112### Hs and Ts (Reversible Causes)
113- **H**ypovolemia, **H**ypoxia, **H**ydrogen ion (acidosis), **H**ypo/hyperkalemia, **H**ypothermia, **H**ypoglycemia
114- **T**ension pneumothorax, **T**amponade, **T**oxins, **T**hrombosis (PE/coronary)
115
116### Equipment Sizing by Broselow Color Zone
117
118| Color | Weight (kg) | ETT (uncuffed) | ETT (cuffed) | Laryngoscope | NG Tube |
119|-------|------------|----------------|--------------|--------------|---------|
120| Grey | 3-5 | 3.5 | 3.0 | Miller 1 | 8 Fr |
121| Pink | 6-7 | 3.5-4.0 | 3.0-3.5 | Miller 1 | 8 Fr |
122| Red | 8-9 | 4.0 | 3.5 | Miller 1-2 | 10 Fr |
123| Purple | 10-11 | 4.5 | 4.0 | Miller 2 | 10 Fr |
124| Yellow | 12-14 | 5.0 | 4.5 | Mac 2 | 12 Fr |
125| White | 15-18 | 5.5 | 5.0 | Mac 2 | 12 Fr |
126| Blue | 19-23 | 6.0 | 5.5 | Mac 2 | 14 Fr |
127| Orange | 24-29 | 6.5 | 6.0 | Mac 3 | 14 Fr |
128| Green | 30-36 | 7.0 | 6.5 | Mac 3 | 16 Fr |
129
130---
131
132## Step 4: Common Pediatric Emergency Presentations
133
134### Fever Without Source (Age-Based Approach)
135
136| Age | Approach | Key Concern |
137|-----|----------|------------|
138| 0-28 days | Full sepsis workup: CBC, blood culture, UA + culture, LP, CXR; admit + empiric antibiotics (ampicillin + gentamicin or cefotaxime) | Late-onset GBS, E. coli, HSV; HSV PCR if risk factors |
139| 29-60 days | Risk stratify using Rochester/Philadelphia/Step-by-Step criteria; low-risk may be managed outpatient with close follow-up | Serious bacterial infection rate 7-10% |
140| 61-90 days | UA + culture; blood culture if ill-appearing; LP if <2 months or ill-appearing | UTI is the most common source |
141| 3-36 months | Evaluate for UTI (especially uncircumcised males <6 months, females <2 years); CXR if respiratory symptoms | Pneumonia, UTI, occult bacteremia (now rare post-PCV13) |
142
143### Pediatric Status Epilepticus Protocol
1441. **0-5 min:** Stabilize (ABCs, glucose, oxygen); benzodiazepine first-line
1452. **5 min:** Midazolam 0.2 mg/kg IM/IN or lorazepam 0.1 mg/kg IV (max 4 mg)
1463. **10 min:** Repeat benzodiazepine once if still seizing
1474. **15-20 min:** Second-line: fosphenytoin 20 mg PE/kg IV or levetiracetam 40-60 mg/kg IV or valproate 20-40 mg/kg IV
1485. **>30 min:** Refractory status epilepticus — consider continuous infusion (midazolam, pentobarbital) and ICU admission
149
150---
151
152## Checkpoint B: Post-Draft Alignment (Mandatory)
153
1541. Was the child's weight accurately determined (measured, Broselow, or age-based estimate) and documented?
1552. Were all medication doses calculated per kilogram with maximum doses verified?
1563. Were vital signs compared against age-adjusted normal ranges?
1574. Were age-specific protocols applied (neonatal fever workup, Broselow equipment sizing)?
1585. Was the legal guardian identified and informed consent documented?
159
160---
161
162## Quality Audit
163
164- [ ] Weight documented in kilograms (measured or estimated with method stated)
165- [ ] Vital signs compared to age-adjusted normal ranges
166- [ ] PAT (Pediatric Assessment Triangle) assessed and documented
167- [ ] All medication doses calculated per kg with max dose cap verified
168- [ ] Epinephrine concentration specified (1:10,000 IV vs. 1:1,000 IM)
169- [ ] Fluid resuscitation documented as mL/kg with reassessment after each bolus
170- [ ] Equipment sizes appropriate for weight/Broselow zone
171- [ ] Age-specific protocols applied (neonatal fever workup, pediatric sepsis, status epilepticus)
172- [ ] Immunization status documented
173- [ ] Caregiver/guardian identified and consent documented
174- [ ] Child abuse screening performed per institutional protocol (bruising in non-mobile children, patterned injuries, inconsistent history)
175- [ ] Pain assessment using age-appropriate tool (FLACC <3 years, Wong-Baker 3-7, NRS >7)
176- [ ] Disposition includes specific pediatric follow-up instructions and return precautions
177
178---
179
180## Guidelines
181
1821. Always weigh children in kilograms — never estimate when a scale is available. Kilogram-only scales prevent the lb/kg conversion errors that account for the majority of 10-fold dosing mistakes.
1832. Use the Broselow tape for all children where actual weight is unknown — tape-based weight estimation is accurate within 10-20% for the majority of children and is far safer than ad hoc guessing.
1843. Never administer D50W (50% dextrose) to children under 8 years — use D10W (5 mL/kg) for neonates and infants, D25W (2 mL/kg) for children 1-8 years.
1854. All febrile neonates (≤28 days) require full sepsis workup including lumbar puncture and empiric antibiotics — do not discharge pending cultures regardless of appearance.
1865. Verify the concentration of epinephrine before every administration — 1:10,000 (0.1 mg/mL) for IV cardiac arrest, 1:1,000 (1 mg/mL) for IM anaphylaxis. Concentration confusion is one of the most lethal medication errors in pediatrics.
1876. Apply the Pediatric Assessment Triangle before touching the child — this 30-second across-the-room assessment provides more prognostic information than vital signs alone.
1887. Screen for child abuse in all pediatric injury presentations — bruising in non-mobile infants (pre-cruising age), patterned injuries, and history inconsistent with developmental stage require mandatory reporting.
1898. Involve parents/caregivers in resuscitation decisions and allow family presence during resuscitation when supported by institutional policy — family presence is endorsed by AHA and AAP.